Trial Profile
A Korean Cohort Study of TDF Rescue Therapy for Difficult-to-treat CHB Patients: a Comparison Between TDF Monotherapy and TDF-based Combination Therapy
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 24 Jul 2018
Price :
$35
*
At a glance
- Drugs Tenofovir disoproxil fumarate (Primary) ; Entecavir; Lamivudine; Telbivudine
- Indications Hepatitis B
- Focus Therapeutic Use
- 15 Jul 2018 Status changed from recruiting to completed.
- 18 Aug 2016 Status changed from not yet recruiting to recruiting.
- 27 Jan 2014 New trial record